Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

Acoustic feedback enables safe and reliable carboplatin delivery across the blood-brain barrier with a clinical focused ultrasound system and improves survival in a rat glioma model.

McDannold N, Zhang Y, Supko JG, Power C, Sun T, Peng C, Vykhodtseva N, Golby AJ, Reardon DA.

Theranostics. 2019 Aug 14;9(21):6284-6299. doi: 10.7150/thno.35892. eCollection 2019.

2.

The neurovascular response is attenuated by focused ultrasound-mediated disruption of the blood-brain barrier.

Todd N, Zhang Y, Livingstone M, Borsook D, McDannold N.

Neuroimage. 2019 Nov 1;201:116010. doi: 10.1016/j.neuroimage.2019.116010. Epub 2019 Jul 11.

PMID:
31302253
3.

Intracranial Non-thermal Ablation Mediated by Transcranial Focused Ultrasound and Phase-Shift Nanoemulsions.

Peng C, Sun T, Vykhodtseva N, Power C, Zhang Y, Mcdannold N, Porter T.

Ultrasound Med Biol. 2019 Aug;45(8):2104-2117. doi: 10.1016/j.ultrasmedbio.2019.04.010. Epub 2019 May 15.

PMID:
31101446
4.

Virtual Brain Projection for Evaluating Trans-skull Beam Behavior of Transcranial Ultrasound Devices.

Brinker ST, Preiswerk F, McDannold NJ, Parker KL, Mariano TY.

Ultrasound Med Biol. 2019 Jul;45(7):1850-1856. doi: 10.1016/j.ultrasmedbio.2019.03.009. Epub 2019 May 3.

PMID:
31060860
5.

MRI Monitoring and Quantification of Ultrasound-Mediated Delivery of Liposomes Dually Labeled with Gadolinium and Fluorophore through the Blood-Brain Barrier.

Aryal M, Papademetriou I, Zhang YZ, Power C, McDannold N, Porter T.

Ultrasound Med Biol. 2019 Jul;45(7):1733-1742. doi: 10.1016/j.ultrasmedbio.2019.02.024. Epub 2019 Apr 19.

PMID:
31010598
6.

Moving toward Noninvasive, Focused Ultrasound Therapeutic Delivery of Drugs in the Brain: Prolonged Opening of Blood-Brain Barrier May Not Be Needed.

Klibanov AL, McDannold NJ.

Radiology. 2019 May;291(2):467-468. doi: 10.1148/radiol.2019190410. Epub 2019 Mar 26. No abstract available.

PMID:
30917292
7.

Modulation of brain function by targeted delivery of GABA through the disrupted blood-brain barrier.

Todd N, Zhang Y, Power C, Becerra L, Borsook D, Livingstone M, McDannold N.

Neuroimage. 2019 Apr 1;189:267-275. doi: 10.1016/j.neuroimage.2019.01.037. Epub 2019 Jan 16.

PMID:
30659957
8.

Simultaneous Passive Acoustic Mapping and Magnetic Resonance Thermometry for Monitoring of Cavitation-Enhanced Tumor Ablation in Rabbits Using Focused Ultrasound and Phase-Shift Nanoemulsions.

Crake C, Papademetriou IT, Zhang Y, Vykhodtseva N, McDannold NJ, Porter TM.

Ultrasound Med Biol. 2018 Dec;44(12):2609-2624. doi: 10.1016/j.ultrasmedbio.2018.07.023. Epub 2018 Sep 8.

PMID:
30201425
9.

Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.

Arvanitis CD, Askoxylakis V, Guo Y, Datta M, Kloepper J, Ferraro GB, Bernabeu MO, Fukumura D, McDannold N, Jain RK.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8717-E8726. doi: 10.1073/pnas.1807105115. Epub 2018 Aug 27.

10.

Scalp sensor for simultaneous acoustic emission detection and electroencephalography during transcranial ultrasound.

Brinker ST, Crake C, Ives JR, Bubrick EJ, McDannold NJ.

Phys Med Biol. 2018 Aug 1;63(15):155017. doi: 10.1088/1361-6560/aad0c2.

11.

Focused ultrasound induced opening of the blood-brain barrier disrupts inter-hemispheric resting state functional connectivity in the rat brain.

Todd N, Zhang Y, Arcaro M, Becerra L, Borsook D, Livingstone M, McDannold N.

Neuroimage. 2018 Sep;178:414-422. doi: 10.1016/j.neuroimage.2018.05.063. Epub 2018 May 29.

12.

High-frequency, low-intensity ultrasound and microbubbles enhance nerve blockade.

Cullion K, Santamaria CM, Zhan C, Zurakowski D, Sun T, Pemberton GL, McDannold NJ, Kohane DS.

J Control Release. 2018 Apr 28;276:150-156. doi: 10.1016/j.jconrel.2018.02.027. Epub 2018 Feb 20. No abstract available.

13.

A dual-mode hemispherical sparse array for 3D passive acoustic mapping and skull localization within a clinical MRI guided focused ultrasound device.

Crake C, Brinker ST, Coviello CM, Livingstone MS, McDannold NJ.

Phys Med Biol. 2018 Mar 15;63(6):065008. doi: 10.1088/1361-6560/aab0aa.

14.

Volumetric analysis of magnetic resonance-guided focused ultrasound thalamotomy lesions.

Harary M, Essayed WI, Valdes PA, McDannold N, Cosgrove GR.

Neurosurg Focus. 2018 Feb;44(2):E6. doi: 10.3171/2017.11.FOCUS17587.

PMID:
29385921
15.

Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.

Sun T, Zhang Y, Power C, Alexander PM, Sutton JT, Aryal M, Vykhodtseva N, Miller EL, McDannold NJ.

Proc Natl Acad Sci U S A. 2017 Nov 28;114(48):E10281-E10290. doi: 10.1073/pnas.1713328114. Epub 2017 Nov 13.

16.

A wireless batteryless implantable radiofrequency lesioning device powered by intermediate-range segmented coil transmitter.

Sai Chun Tang, McDannold NJ, Vaninetti M.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1966-1969. doi: 10.1109/EMBC.2017.8037235.

17.

Combined passive acoustic mapping and magnetic resonance thermometry for monitoring phase-shift nanoemulsion enhanced focused ultrasound therapy.

Crake C, Meral FC, Burgess MT, Papademetriou IT, McDannold NJ, Porter TM.

Phys Med Biol. 2017 Jul 13;62(15):6144-6163. doi: 10.1088/1361-6560/aa77df.

18.

Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma.

Taylor EN, Ding Y, Zhu S, Cheah E, Alexander P, Lin L, Aninwene GE 2nd, Hoffman MP, Mahajan A, Mohamed ASR, McDannold N, Fuller CD, Chen CC, Gilbert RJ.

Oncotarget. 2017 Jun 27;8(26):41815-41826. doi: 10.18632/oncotarget.16296.

19.

Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles.

Aryal M, Fischer K, Gentile C, Gitto S, Zhang YZ, McDannold N.

PLoS One. 2017 Jan 3;12(1):e0166061. doi: 10.1371/journal.pone.0166061. eCollection 2017.

20.

Passive Acoustic Mapping with the Angular Spectrum Method.

Arvanitis CD, Crake C, McDannold N, Clement GT.

IEEE Trans Med Imaging. 2017 Apr;36(4):983-993. doi: 10.1109/TMI.2016.2643565. Epub 2016 Dec 21.

21.

Testing the Efficacy of Contrast-Enhanced Ultrasound in Detecting Transplant Rejection Using a Murine Model of Heart Transplantation.

Fischer K, Ohori S, Meral FC, Uehara M, Giannini S, Ichimura T, Smith RN, Jolesz FA, Guleria I, Zhang Y, White PJ, McDannold NJ, Hoffmeister K, Givertz MM, Abdi R.

Am J Transplant. 2017 Jul;17(7):1791-1801. doi: 10.1111/ajt.14180. Epub 2017 Feb 1.

22.

The Effects of Oxygen on Ultrasound-Induced Blood-Brain Barrier Disruption in Mice.

McDannold N, Zhang Y, Vykhodtseva N.

Ultrasound Med Biol. 2017 Feb;43(2):469-475. doi: 10.1016/j.ultrasmedbio.2016.09.019. Epub 2016 Oct 24.

23.

Preclinical evaluation of a low-frequency transcranial MRI-guided focused ultrasound system in a primate model.

McDannold N, Livingstone M, Top CB, Sutton J, Todd N, Vykhodtseva N.

Phys Med Biol. 2016 Nov 7;61(21):7664-7687. Epub 2016 Oct 14.

24.

Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.

Park J, Aryal M, Vykhodtseva N, Zhang YZ, McDannold N.

J Control Release. 2017 Mar 28;250:77-85. doi: 10.1016/j.jconrel.2016.10.011. Epub 2016 Oct 11.

25.

Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.

Kobus T, Zervantonakis IK, Zhang Y, McDannold NJ.

J Control Release. 2016 Sep 28;238:281-288. doi: 10.1016/j.jconrel.2016.08.001. Epub 2016 Aug 3.

26.

Nonthermal ablation in the rat brain using focused ultrasound and an ultrasound contrast agent: long-term effects.

McDannold N, Zhang Y, Vykhodtseva N.

J Neurosurg. 2016 Dec;125(6):1539-1548. Epub 2016 Feb 5.

27.

Nonthermal ablation of deep brain targets: A simulation study on a large animal model.

Top CB, White PJ, McDannold NJ.

Med Phys. 2016 Feb;43(2):870-82. doi: 10.1118/1.4939809.

28.

Power Loss Analysis and Comparison of Segmented and Unsegmented Energy Coupling Coils for Wireless Energy Transfer.

Tang SC, McDannold NJ.

IEEE J Emerg Sel Top Power Electron. 2015 Mar;3(1):215-225. Epub 2014 Jun 13.

29.

Potential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy.

Fischer K, McDannold NJ, Tempany CM, Jolesz FA, Fennessy FM.

Int J Womens Health. 2015 Nov 13;7:901-12. doi: 10.2147/IJWH.S55564. eCollection 2015. Review.

30.

Safety Validation of Repeated Blood-Brain Barrier Disruption Using Focused Ultrasound.

Kobus T, Vykhodtseva N, Pilatou M, Zhang Y, McDannold N.

Ultrasound Med Biol. 2016 Feb;42(2):481-92. doi: 10.1016/j.ultrasmedbio.2015.10.009. Epub 2015 Nov 23.

31.

Targeted, noninvasive blockade of cortical neuronal activity.

McDannold N, Zhang Y, Power C, Arvanitis CD, Vykhodtseva N, Livingstone M.

Sci Rep. 2015 Nov 6;5:16253. doi: 10.1038/srep16253.

32.

Update on Clinical Magnetic Resonance-Guided Focused Ultrasound Applications.

Kobus T, McDannold N.

Magn Reson Imaging Clin N Am. 2015 Nov;23(4):657-67. doi: 10.1016/j.mric.2015.05.013. Epub 2015 Jul 7. Review.

33.

Evolution of Movement Disorders Surgery Leading to Contemporary Focused Ultrasound Therapy for Tremor.

Ahmed H, Field W, Hayes MT, Lopez WO, McDannold N, Mukundan S Jr, Tierney TS.

Magn Reson Imaging Clin N Am. 2015 Nov;23(4):515-22. doi: 10.1016/j.mric.2015.05.008. Epub 2015 Jul 11. Review.

34.

Cavitation-enhanced nonthermal ablation in deep brain targets: feasibility in a large animal model.

Arvanitis CD, Vykhodtseva N, Jolesz F, Livingstone M, McDannold N.

J Neurosurg. 2016 May;124(5):1450-9. doi: 10.3171/2015.4.JNS142862. Epub 2015 Sep 18.

35.

Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.

Aryal M, Park J, Vykhodtseva N, Zhang YZ, McDannold N.

Phys Med Biol. 2015 Mar 21;60(6):2511-27. doi: 10.1088/0031-9155/60/6/2511. Epub 2015 Mar 6.

36.

Multiple sessions of liposomal doxorubicin delivery via focused ultrasound mediated blood-brain barrier disruption: a safety study.

Aryal M, Vykhodtseva N, Zhang YZ, McDannold N.

J Control Release. 2015 Apr 28;204:60-9. doi: 10.1016/j.jconrel.2015.02.033. Epub 2015 Feb 24.

37.

Transcranial Assessment and Visualization of Acoustic Cavitation: Modeling and Experimental Validation.

Arvanitis CD, Clement GT, McDannold N.

IEEE Trans Med Imaging. 2015 Jun;34(6):1270-81. doi: 10.1109/TMI.2014.2383835. Epub 2014 Dec 25.

38.

Localized delivery of doxorubicin in vivo from polymer-modified thermosensitive liposomes with MR-guided focused ultrasound-mediated heating.

Ta T, Bartolak-Suki E, Park EJ, Karrobi K, McDannold NJ, Porter TM.

J Control Release. 2014 Nov 28;194:71-81. doi: 10.1016/j.jconrel.2014.08.013. Epub 2014 Aug 23.

39.

Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions.

Kopechek JA, Park EJ, Zhang YZ, Vykhodtseva NI, McDannold NJ, Porter TM.

Phys Med Biol. 2014 Jul 7;59(13):3465-81. doi: 10.1088/0031-9155/59/13/3465. Epub 2014 Jun 5.

40.

Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system.

Aryal M, Arvanitis CD, Alexander PM, McDannold N.

Adv Drug Deliv Rev. 2014 Jun;72:94-109. doi: 10.1016/j.addr.2014.01.008. Epub 2014 Jan 22. Review.

41.
42.

Magnetic resonance-guided focused ultrasound: a new technology for clinical neurosciences.

Jolesz FA, McDannold NJ.

Neurol Clin. 2014 Feb;32(1):253-69. doi: 10.1016/j.ncl.2013.07.008. Epub 2013 Nov 8. Review.

43.

Nonthermal ablation with microbubble-enhanced focused ultrasound close to the optic tract without affecting nerve function.

McDannold N, Zhang YZ, Power C, Jolesz F, Vykhodtseva N.

J Neurosurg. 2013 Nov;119(5):1208-20. doi: 10.3171/2013.8.JNS122387. Epub 2013 Sep 6.

44.

Combined ultrasound and MR imaging to guide focused ultrasound therapies in the brain.

Arvanitis CD, Livingstone MS, McDannold N.

Phys Med Biol. 2013 Jul 21;58(14):4749-61. doi: 10.1088/0031-9155/58/14/4749. Epub 2013 Jun 20.

45.

Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model.

Aryal M, Vykhodtseva N, Zhang YZ, Park J, McDannold N.

J Control Release. 2013 Jul 10;169(1-2):103-11. doi: 10.1016/j.jconrel.2013.04.007. Epub 2013 Apr 18.

46.

Accumulation of phase-shift nanoemulsions to enhance MR-guided ultrasound-mediated tumor ablation in vivo.

Kopechek JA, Park E, Mei CS, McDannold NJ, Porter TM.

J Healthc Eng. 2013;4(1):109-26. doi: 10.1260/2040-2295.4.1.109.

47.

Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring.

Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N.

PLoS One. 2012;7(9):e45783. doi: 10.1371/journal.pone.0045783. Epub 2012 Sep 24.

48.

Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.

Park EJ, Zhang YZ, Vykhodtseva N, McDannold N.

J Control Release. 2012 Nov 10;163(3):277-84. doi: 10.1016/j.jconrel.2012.09.007. Epub 2012 Sep 18.

49.

Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles.

Park J, Zhang Y, Vykhodtseva N, Akula JD, McDannold NJ.

PLoS One. 2012;7(8):e42754. doi: 10.1371/journal.pone.0042754. Epub 2012 Aug 13.

50.

Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.

Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K.

Ultrasound Med Biol. 2012 Oct;38(10):1716-25. doi: 10.1016/j.ultrasmedbio.2012.04.015. Epub 2012 Jul 19.

Supplemental Content

Loading ...
Support Center